Michelle R. Padget

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Overcoming hypoxia-induced functional suppression of NK cells”.

Overcoming hypoxia-induced functional suppression of NK cells

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000246

N/A

2.3DataRank · unranked

68 citations

Michelle R. Padget, Kellsye P. Fabian, Benjamin Wolfson, Fabiola Cecchi, Todd Hembrough +6 more

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells

eLife(2020)10.7554/elife.54854

N/A

2.1DataRank · unranked

59 citations

Sarah Greene, Jay Friedman, Paúl E. Clavijo, Carter Van Waes, Kellsye P. Fabian +9 more

Differential combination immunotherapy requirements for inflamed (warm) tumors versus T cell excluded (cool) tumors: engage, expand, enable, and evolve

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2020-001691

N/A

1.8DataRank · unranked

54 citations

Michelle R. Padget, Rika Fujii, Jeffrey Schlom, James W. Hodge, Kellsye P. Fabian

Combination of PARP Inhibitor Olaparib, and PD-L1 Inhibitor Durvalumab, in Recurrent Ovarian Cancer: a Proof-of-Concept Phase II Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0056

N/A

0.813DataRank · unranked

225 citations

Alexandra S. Zimmer, Michelle R. Padget, Ashley Cimino‐Mathews, Jayakumar R. Nair, Yingmiao Liu +13 more

Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells

Cancer Research Communications(2021)10.1158/2767-9764.crc-21-0020

N/A

0.500DataRank · unranked

27 citations

Michelle R. Padget, Kellsye P. Fabian, Anjali Nandal, Gary L. Gallia, Marijo Bilušić +4 more

Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable

Cancer Immunology Research(2020)10.1158/2326-6066.cir-20-0638

N/A

0.434DataRank · unranked

17 citations

Anthony S. Malamas, Michelle R. Padget, Kristen Solocinski, Benjamin Wolfson, Rika Fujii +4 more

Alum-anchored IL-12 combined with cytotoxic chemotherapy and immune checkpoint blockade enhanced antitumor immune responses in head and neck cancer models

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2024-009712

N/A

0.396DataRank · unranked

13 citations

Ginette S. Santiago-Sánchez, Michelle R. Padget, Wiem Lassoued, Clint Allen, Sailaja Battula +3 more

Exploiting the immunogenic potential of standard of care radiation or cisplatin therapy in preclinical models of HPV-associated malignancies

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005752

N/A

0.345DataRank · unranked

9 citations

Kellsye P. Fabian, Michelle R. Padget, Diana C. Lopez, Austin T.K. Hoke, Clint Allen +4 more

Exploiting docetaxel-induced tumor cell necrosis with tumor targeted delivery of IL-12

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03459-7

N/A

0.312DataRank · unranked

7 citations

Ginette S. Santiago-Sánchez, Kellsye P. Fabian, Kristen Solocinski, Paul L. Chariou, Duane H. Hamilton +6 more

Targeting sinonasal undifferentiated carcinoma with a combinatory immunotherapy approach

Translational Oncology(2024)10.1016/j.tranon.2024.101943

N/A

0.269DataRank · unranked

5 citations

Yoko Takahashi, Michelle R. Padget, Javier A. Gomez, Moran Amit, Jared K. Burks +7 more

Tumor control via targeting PD-L1 with chimeric antigen receptor modified NK cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.30.926535

N/A

0.208DataRank · unranked

3 citations

Sarah Greene, Jay Friedman, Paúl E. Clavijo, Carter Van Waes, Kellsye P. Fabian +9 more

Chordoma cancer stem cell subpopulation characterization may guide targeted immunotherapy approaches to reduce disease recurrence

Frontiers in Oncology(2024)10.3389/fonc.2024.1376622

N/A

0.208DataRank · unranked

3 citations

Kellsye P. Fabian, Michelle R. Padget, Yvette Robbins, Joshua T. Kowalczyk, Wiem Lassoued +7 more

Combination of a novel TCR Vβ chain-directed selective T cell activator with standard of care therapy for head and neck cancer improves antitumor responses and promotes regression of checkpoint-refractory tumor models

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-013158

N/A

0.165DataRank · unranked

2 citations

Ginette S. Santiago-Sánchez, Kellsye P. Fabian, Michelle R. Padget, J Lee, Clint Allen +7 more

Data from Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable

(2023)10.1158/2326-6066.c.6550240

N/A

0DataRank · unranked

0 citations

Anthony S. Malamas, Michelle R. Padget, Kristen Solocinski, Benjamin Wolfson, Rika Fujii +4 more

Data from Therapy of Established Tumors with Rationally Designed Multiple Agents Targeting Diverse Immune–Tumor Interactions: Engage, Expand, Enable

(2023)10.1158/2326-6066.c.6550240.v1

N/A

0DataRank · unranked

0 citations

Anthony S. Malamas, Michelle R. Padget, Kristen Solocinski, Benjamin Wolfson, Rika Fujii +4 more